The therapeutic effect of autologous bone marrow mesenchymal stem cells to prevent the progress of chronic allograft nephropathy
| Autor: | Ali Ghasemi, Ahmad Reza Bahrami, Hamid Reza Bidkhouri, Masoud Pezeshki Rad, Hojat Naderi Mishkin, Farhad Gholami, Farzaneh Sharifipour |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
030506 rehabilitation
business.industry Urology Regeneration (biology) Mesenchymal stem cell medicine.disease Regenerative medicine End stage renal disease 03 medical and health sciences Paracrine signalling 0302 clinical medicine Nephrology Chronic allograft nephropathy Cancer research medicine Progenitor cell Stem cell 0305 other medical science business 030217 neurology & neurosurgery |
| Zdroj: | Journal of Renal Injury Prevention. 8:1-5 |
| ISSN: | 2345-2781 |
| DOI: | 10.15171/jrip.2019.01 |
| Popis: | Progenitor cells or mesenchymal stem cells are new cells, with renovation and regeneration ability and tissues repair. In recent years, administration of stem cells has been introduced to treat a variety of diseases including chronic allograft injury (CAI). It seems that stem cells can create a turning point in regenerative medicine through repair, replacement with damaged tissues or with their paracrine effects. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|